DSM-Firmenich AG (LON:0AC9)
London flag London · Delayed Price · Currency is GBP · Price in EUR
93.32
+0.21 (0.23%)
At close: Apr 24, 2025

DSM-Firmenich AG Company Description

DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia.

The company operates through four segments: Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health.

The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and sugar reduction; and food enzymes, hydrocolloids, cultures, natural colorants, nutritional ingredients, and plant-based proteins.

The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, biomedical materials, and nutrition improvement markets.

This segment also offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, postbiotics, probiotics and prebiotics, and active pharmaceutical ingredients; biomedical solutions; and premix, market-ready, and personalized nutrition solutions, as well as expert services in regulatory affairs and nutrition.

The Animal Nutrition & Health segment offers animal proteins, vitamins, performance solutions, and data-driven precision services.

The company was founded in 1902 and is based in Kaiseraugst, Switzerland.

DSM-Firmenich AG
Country Switzerland
Founded 1902
Industry Chemicals and Allied Products
Employees 26,301
CEO Dimitri de Vreeze

Contact Details

Address:
Wurmisweg 576
Kaiseraugst, 4303
Switzerland
Phone 41 61 815 17 26
Website dsm-firmenich.com

Stock Details

Ticker Symbol 0AC9
Exchange London Stock Exchange
Fiscal Year January - December
Reporting Currency EUR
SIC Code 2800

Key Executives

Name Position
Dimitri de Vreeze Chief Executive Officer
Ralf Schmeitz Chief Financial Officer
Emmanuel Butstraen Chief Operating Officer
Dave Huizing Head of Investor Relations